Soolantra FDA Approval History
FDA Approved: Yes (First approved December 19, 2014)
Brand name: Soolantra
Generic name: ivermectin
Dosage form: Cream
Company: Galderma Laboratories, L.P.
Treatment for: Rosacea
Soolantra (ivermectin) is a topical antiparasitic with anti-inflammatory properties for the treatment of rosacea potentially caused by the microscopic skin mite Demodex folliculorum.
Development Timeline for Soolantra
|Dec 23, 2014||Approval Galderma Receives FDA Approval of Soolantra (ivermectin) Cream for Rosacea|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.